🇺🇸 FDA

Intelligence · Patent portfolio

Teva Pharma Patents

Full USPTO pharma patent portfolio for Teva Pharma — grant dates, expiration, and drug cross-links.

Patents
454
Expiring ≤24m
49

Quick answer

Teva Pharma has 454 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 49 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 10

  1. US 12310929

    Use of rasagiline for the treatment of restless legs syndrome

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12258401

    Anti-CD47 combination therapy

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12157729

    Solid state forms of Belumosudil and Belumosudil salts

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12139528

    Treating refractory migraine

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12091388

    Solid state forms of Reproxalap

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11826322

    Pre-filled syringe

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11813359

    Sustained release olanzapine formulations

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11773083

    Solid state forms of Belumosudil and Belumosudil salts

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11673860

    Crystalline siponimod fumaric acid and polymorphs thereof

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11618784

    Anti-CD47 combination therapy

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11578338

    Hemipteran active insecticidal protein

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11555064

    Treating headache comprising administering an antibody to calcitonin gene-related peptide

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11541177

    Injection spring for aged prefilled syringe and auto injector

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11472772

    S1P3 antagonists

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11420945

    Solid state forms of Pemafibrate

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11399540

    Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11319356

    Interferon alpha 2B variants

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11306104

    Solid state forms of Relugolix

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11297838

    Pesticidal compositions and methods

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11253591

    Combination of lenalidomide and polypeptide construct, and uses thereof

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11220488

    Crystalline polymorph of Ponesimod

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11135154

    Medroxyprogesterone acetate injectable compositions and methods of use

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11117975

    Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11053261

    Solid state forms of ixazomib citrate

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11028160

    Treating refractory migraine

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11028161

    Treating refractory migraine

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10981986

    Fusions of antibodies to CD38 and attenuated interferon alpha

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10899826

    Pharmaceutical compositions for an anti-CGRP antagonist antibody

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10835503

    Pre-filled syringe

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10822422

    Antibodies against TL1a and uses thereof

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10689352

    Solid state forms of trisodium valsartan: sacubitril

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10676498

    Processes for the preparation of sofosbuvir and intermediates thereof

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10653704

    Inhalable formulation

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10646443

    Sustained release olanzapine formulations

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10640487

    Solid state forms of Nilotinib salts

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10604537

    Solid state forms of ixazomib citrate

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10597448

    Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10556945

    Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10544199

    Interferon alpha 2B variants

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10519224

    Treating headache comprising administering an antibody to calcitonin gene-related peptide

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10392434

    Treating refractory migraine

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10342867

    Adjuvants

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10329343

    Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10323085

    Methods of treating fibromyalgia

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10314819

    Solid state forms of Eluxadoline

    Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10232041

    Combination of lenalidomide and polypeptide construct, and uses thereof

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10214553

    Solid state forms of sofosbuvir

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10188648

    Solid state forms of selexipag

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Teva Pharma have?

454 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Teva Pharma patents expire?

49 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.